Cydan, LLC , an orphan drug accelerator that identifies and de-risks programs with therapeutic and commercial potential, today announced its launch with $16 million in financing led by New Enterprise Associates and Pfizer Venture Investments, with participation from Alexandria Real Estate Equities, Inc.
http://www.freshnews.com/news/783824/cydan-new-orphan-drug-accelerator-launches-16-million-financing-leading-investors-nea-p
http://www.freshnews.com/news/783824/cydan-new-orphan-drug-accelerator-launches-16-million-financing-leading-investors-nea-p
No comments:
Post a Comment